This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.
from Hindustan Times - india https://ift.tt/2XJ8srh
via IFTTT
from Hindustan Times - india https://ift.tt/2XJ8srh
via IFTTT


No comments